Results 261 to 270 of about 343,938 (360)
Both native and engineered extracellular vesicles (EVs) are served as promising therapeutic agents for treating acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). To circumvent the limitations of native EVs, various engineering strategies are adopted.
Zhengyan Gu+12 more
wiley +1 more source
Advancements in biomarkers and machine learning for predicting of bronchopulmonary dysplasia and neonatal respiratory distress syndrome in preterm infants. [PDF]
Talebi H+13 more
europepmc +1 more source
Preserving the Surface Activity of Lung Surfactant Using Soft Nebulization
This study examines the integrity and surface activity of animal‐derived lung surfactant under different nebulizations. Low‐energy nebulization preserves lamellar structures of the surfactant, enhancing rapid spreading and stability in maintaining low surface tension during interface area changes.
Kaili Xie+6 more
wiley +1 more source
A Rare Case of Giant Inguinoscrotal Bladder Hernia as a Cause of Acute Respiratory Distress Syndrome. [PDF]
Neff T, Amicone C.
europepmc +1 more source
Research indicated that extremely low‐frequency (ELF) electric field (EF) treatment modifies autonomic activity in healthy subjects; however, the effects do not persist after the treatment. This study examined whether persistence of the effects is dependent on the baseline autonomic conditions.
Toshikazu Shinba+2 more
wiley +1 more source
An animal model of severe acute respiratory distress syndrome for translational research. [PDF]
Chu KA+8 more
europepmc +1 more source
ABSTRACT Sepsis remains the leading cause of multiple‐organ injury due to endotoxemia. Astaxanthin (ASTA), widely used in marine aquaculture, has an extraordinary potential for antioxidant and anti‐inflammatory activity. Purinergic receptor (e.g., P2X7R) activation is a powerful signaling in the modulation of inflammation.
Seckin Ozkanlar+3 more
wiley +1 more source
A novel UBA1 gene mutation in a patient with infantile respiratory distress syndrome. [PDF]
Miyata M+8 more
europepmc +1 more source